ANDA 89104, held by Superpharm. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 89104 (Thioridazine Hydrochloride), held by Superpharm, was first approved by FDA on Jul 2, 1985, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 2, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride25MG ยท tablet;oral | Thioridazine Hydrochloride | Discontinued |
| Jun 19, 1991 | Supplement 17Labeling | Approved | None posted |
| Feb 8, 1989 | Supplement 13Labeling | Approved | None posted |
| Jul 2, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters